These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1900306)

  • 41. Propranolol Reduces Portal Vein Diameter in Schistosomal Liver Disease with Portal Hypertension: A Prospective Cohort Study.
    Sinkala E; Vinikoor M; Zyambo K; Besa E; Nsokolo B; Kelly P
    Am J Trop Med Hyg; 2020 Apr; 102(4):832-837. PubMed ID: 32067625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Further studies on genetic variation of hepatosplenic disease and modulation in murine schistosomiasis mansoni.
    Fanning MM; Kazura JW
    Parasite Immunol; 1985 May; 7(3):213-22. PubMed ID: 4011297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of propanolol on portosystemic shunting.
    Blendis LM
    Hepatology; 1991 Nov; 14(5):952-3. PubMed ID: 1937400
    [No Abstract]   [Full Text] [Related]  

  • 44. [The effects of propranolol or nitroglycerin on azygos blood flow in patients with portal hypertension].
    Notsumata K
    Nihon Shokakibyo Gakkai Zasshi; 1986 Aug; 83(8):1489-97. PubMed ID: 3097355
    [No Abstract]   [Full Text] [Related]  

  • 45. Ultrasonographic evaluation of gallbladder function in patients with Schistosoma mansoni infection.
    Ali QM; Abdel-Rahim IM; Doehring-Schwertfegar E; Franke D; Kardorff R; el Sheikh M; Ehrich JH
    Trop Doct; 1990 Jul; 20(3):113-5. PubMed ID: 2120820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Haemodynamic rebound phenomena after abrupt cessation of propranolol therapy in portal hypertensive rats.
    Lee SS; Braillon A; Girod C; Geoffroy P; Lebrec D
    J Hepatol; 1986; 3(1):38-41. PubMed ID: 3018073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Schistosoma mansoni infection enhances host portal vein contraction: role of potassium channels and p38 MAP kinase.
    Araujo FP; Quintas LE; Noël F; Silva CL
    Microbes Infect; 2007 Jul; 9(8):1020-5. PubMed ID: 17544802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The implantation of sepharose beads in mouse livers as an aid in the study of hepatic schistosomal fibrosis.
    van Marck EA; Stocker S; Grimaud JA; Kestens L; Gigase PL; Deelder AM
    Experientia; 1980 Sep; 36(9):1116-8. PubMed ID: 7191376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Portal pressure response to propranolol in portal hypertension.
    Ozsoylu S; Koçak N; Yüce A; Ozbag E
    J Hepatol; 1992 May; 15(1-2):270-1. PubMed ID: 1506652
    [No Abstract]   [Full Text] [Related]  

  • 50. Colchicine therapy for hepatic murine schistosomal fibrosis: image analysis and serological study.
    Badawy AA; el-Badrawy NM; Hassan MM; Ebeid FA
    Int J Exp Pathol; 1999 Feb; 80(1):25-34. PubMed ID: 10365084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamics of hepatic connective tissue matrix constituents during murine Schistosoma mansoni infection.
    el-Meneza S; Olds GR; Kresina TF; Mahmoud AA
    Hepatology; 1989 Jan; 9(1):50-6. PubMed ID: 2535698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Propranolol for portal hypertension.
    Dominguez P
    Lancet; 1981 Jun; 1(8233):1322-3. PubMed ID: 6112641
    [No Abstract]   [Full Text] [Related]  

  • 53. Thrombocytemia as a predictor of portal hypertension in schistosomiasis.
    Souza MR; Toledo CF; Borges DR
    Dig Dis Sci; 2000 Oct; 45(10):1964-70. PubMed ID: 11117568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic murine hepatosplenic schistosomiasis mansoni: relative irreversibility after treatment.
    Warren KS; Klein L
    Trans R Soc Trop Med Hyg; 1969; 63(3):333-7. PubMed ID: 4307556
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of propranolol on renal blood flow in portal hypertensive rats.
    Cales P; Braillon A; Girod C; Lebrec D
    Gastroenterology; 1985 Mar; 88(3):857. PubMed ID: 3967812
    [No Abstract]   [Full Text] [Related]  

  • 56. Risk of hepatic encephalopathy in patients taking propranolol for portal hypertension.
    Reding P
    Lancet; 1982 Sep; 2(8297):550. PubMed ID: 6125697
    [No Abstract]   [Full Text] [Related]  

  • 57. Propranolol to lower portal venous pressure.
    Fleishman SJ
    Lancet; 1981 Feb; 1(8216):382-3. PubMed ID: 6110009
    [No Abstract]   [Full Text] [Related]  

  • 58. Leaky livers, portal shunting and immunity to schistosomes.
    Wilson RA
    Parasitol Today; 1990 Nov; 6(11):354-8. PubMed ID: 15463268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Propranolol in the management of portal hypertension.
    Dwivedi M; Misra SP
    Natl Med J India; 1990; 3(1):10-16. PubMed ID: 29865127
    [No Abstract]   [Full Text] [Related]  

  • 60. β-Blockers in Hepatosplenic Schistosomiasis: A Narrative Review.
    Gelape FA; Couto CA; Cançado GGL
    Am J Trop Med Hyg; 2023 Dec; 109(6):1213-1219. PubMed ID: 37931294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.